
Sulbasure 250mg/125mg Injection
Marketer
Gentech Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Sulbasure 250mg/125mg Injection
Combiflox 250mg/125mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration of Combiflox 250mg/125mg Injection necessitates strict medical oversight. Consistent adherence to the prescribed dosage schedule is crucial; premature cessation can compromise efficacy. Complete the entire treatment course, even with symptom improvement. Minor side effects, such as nausea, vomiting, diarrhea, and dyspepsia, may occur. Severe or persistent side effects warrant immediate medical attention. Allergic reactions (including rash, pruritus, edema, or dyspnea) require prompt emergency care. Inform your physician of all current medications and pre-existing conditions before commencing treatment. This medication requires careful consideration for pregnant or lactating individuals. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occur. Adequate rest, nutritious food, and ample hydration contribute to faster recovery. Your doctor may order blood tests and imaging studies to monitor treatment effectiveness.
Uses of Sulbasure 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Sulbasure 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Sulbasure 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Sulbasure 250mg/125mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Sulbasure 250mg/125mg Injection works:
Ceftriaxone/Sulbactam 250mg/125mg Injection (Sulbasure) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counters bacterial resistance, thus bolstering Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of alcohol and Sulbasure 250mg/125mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Sulbasure, 250mg/125mg, is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human studies are scarce.
Breast feedingCAUTION
The administration of Sulbasure 250mg/125mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the course of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Sulbasure 250mg/125mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Sulbasure 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable medication, Sulbasure 250mg/125mg, requires careful administration to individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Sulbasure 250mg/125mg Injection are unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Sulbasure 250mg/125mg Injection :
Should you inadvertently skip a dose of the Sulbasure 250mg/125mg injection, seek medical advice.
Facts to Know About Sulbasure 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
